Bulk Vinblastine Sulfate and Prednisone Injectable Base from Japan
Mixed base solution of vinblastine sulfate (alkaloid from vinca) and prednisone for oncology protocols, supplied for hospital dilution. HTS 3003.49.00.00 for bulk multi-constituent alkaloid medicaments not retail-packed.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• FDA biologics license may be required for vinca alkaloid antineoplastics; pre-submit import data
• Document cytotoxic handling protocols to meet hazmat import requirements
• Confirm no measured doses in bulk drums to maintain 3003 classification